# SOPHiA GENETICS to Announce Financial Results for the Fourth Quarter and Full-Year 2023 on March 5, 2024
Canonical URL: https://biopharmsignal.com/news/SOPH/sophia-genetics-to-announce-financial-results-for-the-fourth-quarter-and-full-ye-6069e388
Ticker: SOPH
Company: Sophia Genetics
Source: Sophia Genetics
Published: 2024-02-20 15:46 EST
## Summary

SOPHiA GENETICS to Announce Financial Results for the Fourth Quarter and Full Year 2023 on March 5, 2024 ...

## Article Body
SOPHiA GENETICS (Nasdaq: SOPH), a cloud-native software company and a leader in data-driven medicine, today announced it will release its financial results for the fourth quarter and full-year 2023 before U.S. markets open on Tuesday, March 5, 2024. On that day, SOPHiA GENETICS will host a conference call to discuss its financial results as well as business outlook beginning at 8:00 a.m. (08:00) EDT / 2:00 p.m. (14:00) CET.

The call will be webcast live on the SOPHiA GENETICS Investor Relations website . Additionally, a replay will be available on the website after its completion.

About SOPHiA GENETICS

SOPHiA GENETICS (Nasdaq: SOPH) is a software company dedicated to establishing the practice of data-driven medicine as the standard of care and for life sciences research. It is the creator of the SOPHiA DDM™ Platform, a cloud-native platform capable of analyzing data and generating insights from complex multimodal data sets and different diagnostic modalities. The SOPHiA DDM™ Platform and related solutions, products, and services are currently used by a broad network of hospital, laboratory, and biopharma institutions globally. For more information, visit SOPHiAGENETICS.COM , or connect on X , LinkedIn , Facebook , and Instagram . Where others see data, we see answers.
## Recent Company News
- 2024-06-24 13:47 EST — [SOPHiA GENETICS Publishes Results of 2024 Annual General Meeting](https://biopharmsignal.com/news/SOPH/sophia-genetics-publishes-results-of-2024-annual-general-meeting-cd3af75f) — Source: Sophia Genetics
- 2024-05-07 10:45 EST — [SOPHiA GENETICS Reports First Quarter 2024 Results](https://biopharmsignal.com/news/SOPH/sophia-genetics-reports-first-quarter-2024-results-e1a64b37) — Source: Sophia Genetics
- 2024-04-30 11:05 EST — [SOPHiA GENETICS to Present at the 2024 RBC Capital Markets Global Healthcare Conference](https://biopharmsignal.com/news/SOPH/sophia-genetics-to-present-at-the-2024-rbc-capital-markets-global-healthcare-con-9aa966bb) — Source: Sophia Genetics
- 2024-04-23 14:29 EST — [SOPHiA GENETICS to Announce Financial Results for First Quarter 2024 on May 7, 2024](https://biopharmsignal.com/news/SOPH/sophia-genetics-to-announce-financial-results-for-first-quarter-2024-on-may-7-20-f68ce487) — Source: Sophia Genetics
- 2024-03-07 17:07 EST — [SOPHiA GENETICS to Present at the Barclays 26th Annual Global Healthcare Conference](https://biopharmsignal.com/news/SOPH/sophia-genetics-to-present-at-the-barclays-26th-annual-global-healthcare-confere-76cb280c) — Source: Sophia Genetics
## Related News
- 2026-07-29 14:05 EST — CAPR — [The Lancet Publishes HOPE-3 Data for Capricor Therapeutics’ Deramiocel in Duchenne Muscular Dystrophy](https://biopharmsignal.com/news/CAPR/the-lancet-publishes-hope-3-data-for-capricor-therapeutics-deramiocel-in-duchenn-9e6e6bd9)
- 2026-07-29 13:00 EST — ENLV — [Enlivex Management to Host Webinar to Discuss Capital Strategy, Rain Protocol Treasury Strategy, and Recent Clinical Milestones](https://biopharmsignal.com/news/ENLV/enlivex-management-to-host-webinar-to-discuss-capital-strategy-rain-protocol-tre-5921a627)
- 2026-07-29 12:30 EST — PRGO — [Perrigo to Present at the Canaccord 46th Annual Growth Conference](https://biopharmsignal.com/news/PRGO/perrigo-to-present-at-the-canaccord-46th-annual-growth-conference-40431922)
- 2026-07-29 12:30 EST — LIXT — [NOMAD Announces Operational Deployment of Two Mobile Battery Systems by DSO Electric Cooperative](https://biopharmsignal.com/news/LIXT/nomad-announces-operational-deployment-of-two-mobile-battery-systems-by-dso-elec-7fc12a2c)
- 2026-07-29 12:30 EST — RNXT — [RenovoRx to Host Second Quarter 2026 Financial Results and Business Highlights Conference Call on August 12th at 4:30 p.m. ET](https://biopharmsignal.com/news/RNXT/renovorx-to-host-second-quarter-2026-financial-results-and-business-highlights-c-8bed10ec)